BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21771727)

  • 21. Differential methylation of a short CpG-rich sequence within exon 1 of TCF21 gene: a promising cancer biomarker assay.
    Shivapurkar N; Stastny V; Xie Y; Prinsen C; Frenkel E; Czerniak B; Thunnissen FB; Minna JD; Gazdar AF
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):995-1000. PubMed ID: 18398044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.
    Andolfo I; Liguori L; De Antonellis P; Cusanelli E; Marinaro F; Pistollato F; Garzia L; De Vita G; Petrosino G; Accordi B; Migliorati R; Basso G; Iolascon A; Cinalli G; Zollo M
    Neuro Oncol; 2012 May; 14(5):596-612. PubMed ID: 22411914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
    Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
    Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients.
    Cebrian V; Fierro M; Orenes-Piñero E; Grau L; Moya P; Ecke T; Alvarez M; Gil M; Algaba F; Bellmunt J; Cordon-Cardo C; Catto J; López-Beltrán A; Sánchez-Carbayo M
    Am J Pathol; 2011 Aug; 179(2):540-6. PubMed ID: 21683672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX4 has the potential to function as a tumor suppressor in human melanoma.
    Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
    Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of tumor suppressor gene TCF21 on the proliferation, migration and apoptosis of A549 cells].
    Hu S; Yang N; Chen M; Guo J; Xian L
    Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):302-7. PubMed ID: 24758904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.
    Cheng YY; Kirschner MB; Cheng NC; Gattani S; Klebe S; Edelman JJ; Vallely MP; McCaughan BC; Jin HC; van Zandwijk N; Reid G
    J Thorac Oncol; 2013 Oct; 8(10):1317-28. PubMed ID: 24457242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
    Fujimoto A; Takeuchi H; Taback B; Hsueh EC; Elashoff D; Morton DL; Hoon DS
    Cancer Res; 2004 Mar; 64(6):2245-50. PubMed ID: 15026369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
    Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
    Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of TCF21 is associated with poor survival in clear cell renal cell carcinoma.
    Ye YW; Jiang ZM; Li WH; Li ZS; Han YH; Sun L; Wang Y; Xie J; Liu YC; Zhao J; Tang AF; Li XX; Guan ZC; Gui YT; Cai ZM
    Neoplasma; 2012; 59(6):599-605. PubMed ID: 22862160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic BRAFV600E induces expression of neuronal differentiation marker MAP2 in melanoma cells by promoter demethylation and down-regulation of transcription repressor HES1.
    Maddodi N; Bhat KM; Devi S; Zhang SC; Setaluri V
    J Biol Chem; 2010 Jan; 285(1):242-54. PubMed ID: 19880519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The metastasis suppressor KISS1 lacks antimetastatic activity in the C8161.9 xenograft model of melanoma.
    Navenot JM; Evans B; Oishi S; Setsuda S; Fujii N; Peiper SC
    Melanoma Res; 2012 Apr; 22(2):140-50. PubMed ID: 22395416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
    Hoon DS; Spugnardi M; Kuo C; Huang SK; Morton DL; Taback B
    Oncogene; 2004 May; 23(22):4014-22. PubMed ID: 15064737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.
    Gao L; Smit MA; van den Oord JJ; Goeman JJ; Verdegaal EM; van der Burg SH; Stas M; Beck S; Gruis NA; Tensen CP; Willemze R; Peeper DS; van Doorn R
    Pigment Cell Melanoma Res; 2013 Jul; 26(4):542-54. PubMed ID: 23590314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of Wnt inhibitory factor-1 in human esophageal squamous cell carcinoma.
    Yang SH; Li SL; Dong ZM; Kan QC
    Oncol Res; 2012; 20(2-3):123-30. PubMed ID: 23193918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
    Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
    Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological significance and biological role of TCF21 mRNA in breast cancer.
    Wang J; Gao X; Wang M; Zhang J
    Tumour Biol; 2015 Nov; 36(11):8679-83. PubMed ID: 26044559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP.
    Goldberg SF; Miele ME; Hatta N; Takata M; Paquette-Straub C; Freedman LP; Welch DR
    Cancer Res; 2003 Jan; 63(2):432-40. PubMed ID: 12543799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation characteristics of primary melanomas with distinct biological behaviour.
    Ecsedi S; Hernandez-Vargas H; Lima SC; Vizkeleti L; Toth R; Lazar V; Koroknai V; Kiss T; Emri G; Herceg Z; Adany R; Balazs M
    PLoS One; 2014; 9(5):e96612. PubMed ID: 24832207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.